FdaApplication
NDA 219122
Identifiers
- fda_app_no: NDA219122
Properties
| Property | Value |
|---|---|
| applicant_name | AZURITY PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2025-01-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BRYNOVIN | SITAGLIPTIN HYDROCHLORIDE | EQ 25MG BASE/ML | SOLUTION;ORAL |
1 product